Factors Affecting the Price of Retevmo

Retevmo (selpercatinib) is a pricey drug for specific cancers. 

Factors Affecting the Price of Retevmo

R&D expenses are a major factor. Developing this RET inhibitor involved extensive research and costly clinical trials. Production costs matter too. Specialized manufacturing processes and strict quality control add to the price.

Market forces play a role. In regions with high demand and limited supply, prices tend to be higher. Patent protection also allows the manufacturer, Eli Lilly, to maintain a high price. Moreover, healthcare policies vary. Some countries’ insurance coverage can reduce the out - of - pocket cost for patients, while in others, patients may bear the full brunt of the high price.